SCIENTIFIC BACKGROUND

APOC2

 

SCIENTIFIC BACKGROUND

Due to its central role in the activation of lipoprotein lipase (Lpl), apolipoprotein C-II (Apo C-II) plays an important role in the metabolism of triglyceride-rich lipoproteins, especially chylomicrons. Primary Apo C-II deficiency is a rare autosomal recessive inherited metabolic defect characterized by extremely elevated serum concentrations of triglycerides (up to 30,000 mg/dl) and chylomicrons (milky creamy serum, Fredrickson's hyperlipidemia type I). In addition to the hereditary form, an acquired, reversible form of apo C-II deficiency has also been described, which can be caused, for example, by chemotherapy. The diagnosis is mostly made in the context of recurrent pancreatitis (DD: hereditary pancreatitis); eruptive xanthomas and hepatomegaly are common phenotypic features that occur only in the congenital form. Apo C-II deficiency is not associated with increased coronary risk. Treatment consists of a low-fat diet, alcohol abstinence, and administration of fibrates when appropriate. Fibrates induce the expression of Lpl through activation of the transcription factor PPARalpha, which can further lower serum triglyceride concentrations. Therefore, fibrate therapy is only beneficial if the LPL gene is intact. Because LPL deficiency is also associated with type I hyperlipidemia, molecular genetic analysis of the LPL gene may be useful in the context of treatment planning.

 

The disease is caused by homozygous or mixed heterozygous pathogenic variants in the APOC2 gene that secondarily lead to functional Lpl deficiency. The APOC2 gene is located on chromosome 19 and is localized in the APOE/APOC1/APOC2 gene cluster.

 

References

Wolska et al. 2017, Atherosclerosis 267:49 / Mendoza-Barberá et al. 2013, J Lipid Res 54:649 / Brahm et Hegele 2013, Nutrients 5:981 / Burnett et al. 2017, GeneReviews® [Internet]

GENES

APOC2

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Cystic fibrosis (CF) is a life-threatening, progressive, inherited condition that causes severe damage to the body, primarily affecting the organs of...

Read more

Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. It affects physical growth, facial features, and cogni...

Read more

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more